Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli

被引:7
|
作者
Seckin, Ismail [1 ]
Uzunalan, Mumin [1 ]
Pekpak, Meltem [2 ]
Kokturk, Sibel [3 ]
Sonmez, Huseyin [4 ]
Ozturk, Zeynep [4 ]
Demirci, Sibel [1 ]
Yaprak, Elif [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Fac Med, Dept Histol & Embryol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Fac Med, Dept Nephrol, Istanbul, Turkey
[3] Kocaeli Univ, Fac Med, Dept Histol & Embryol, Kocaeli, Turkey
[4] Istanbul Univ, Cerrahpasa Fac Med, Dept Biochem, Istanbul, Turkey
关键词
puromycine aminonucleoside nephritis; PD-ECGF; angiogenesis; macrophage; ultrastructure; rat; BLOOD-VESSEL FORMATION; THYMIDINE PHOSPHORYLASE; LUMEN FORMATION; FACTOR/THYMIDINE PHOSPHORYLASE; PODOCYTE; ALPHA(5)BETA(1); ALPHA(V)BETA(3); VASCULOGENESIS; RECEPTORS; INTEGRINS;
D O I
10.1186/1423-0127-19-24
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: In experimentally induced puromycine aminonucleoside nephrosis (PAN) animal models, nephrotic syndrome with minimal change disease and focal and segmental sclerosis-like nephritis similar to that in human is demonstrated; however, the real mechanism of PAN is not yet elucidated. Platelet derived endothelial cell growth factor (PD-ECGF), an endothelial mitogen protein, is believed to take part in microvessel formation and in stimulation of angiogenesis and its expression has not been totally demonstrated in PAN rats yet. In this study, we aimed to examine PD-ECGF expression in acute and chronic PAN induced in rats and find out the association between its expression and the stages of angiogenesis in kidney. Methods: For the experiment, twenty-four Male Wistar Albino rats were used and divided into four groups; control group (n = 6), pre-proteinuria group (n = 6), acute group (n = 6) and chronic group (n = 6). We compared statistically all data by One-way ANOVA Test followed by Dunn Multiple Comparison Test. Results: Proteinurea levels in control and pre-proteinuria groups were not statistically different; however, it was remarkably higher in the acute nephrosis group and significantly greater in the chronic nephrosis group than control group (p < 0.0025). In pre-proteinuria group, the serum albumin and creatinine clearances also did not significantly differ from the control group. On the other hand, in the acute and chronic nephrosis groups, serum albumin and creatinine clearances progressively decreased (p < 0.05). In our immunohistochemical studies, we showed elevated PD-ECGF expression in glomeruli of acute and chronic PAN rats. Microscopic and ultrastructural appearances of the glomeruli of acute and chronic PAN showed various sequential steps of angiogenesis, macrophages and immature capillaries with primitive lumens and apoptotic endothelial cells in the increased mesangial matrix. Conclusions: It is reported that acute and chronic PAN progressively increase PD-ECGF expression and following induction of angiogenesis in the affected glomeruli.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Expression of platelet-derived endothelial cell growth factor and its mRNA in uterine endometrium during the menstrual cycle
    Fujimoto, J
    Ichigo, S
    Sakaguchi, H
    Hirose, R
    Tamaya, T
    MOLECULAR HUMAN REPRODUCTION, 1998, 4 (05) : 509 - 513
  • [42] Platelet-derived endothelial cell growth factor thymidine phosphorylase immunohistochemical expression in lymphoid tissue and lymphoid malignancies
    DoussisAnagnostopoulou, IA
    Remadi, S
    Turley, H
    Gindre, P
    Comley, M
    Borisch, B
    Gatter, KC
    HUMAN PATHOLOGY, 1997, 28 (10) : 1146 - 1151
  • [43] IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma
    Fujieda, S
    Sunaga, H
    Tsuzuki, H
    Fan, GK
    Saito, H
    CANCER LETTERS, 1999, 136 (01) : 1 - 9
  • [44] Platelet-derived endothelial cell growth factor thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer
    Nagaoka, H
    Iino, Y
    Takei, H
    Morishita, Y
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (03) : 449 - 454
  • [45] Platelet-derived endothelial cell growth factor expression is an independent prognostic factor in colorectal cancer patients after curative surgery
    Tsuji, T
    Sawai, T
    Yamashita, H
    Takeshita, H
    Nakagoe, T
    Shindou, H
    Fukuoka, H
    Yoshinaga, M
    Hidaka, S
    Yasutake, T
    Nagayasu, T
    Tagawa, Y
    EJSO, 2004, 30 (03): : 296 - 302
  • [46] Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma
    Ueda, T
    Tamaki, M
    Ogawa, O
    Yoshimura, N
    JOURNAL OF UROLOGY, 2002, 167 (01) : 347 - 351
  • [47] Dual neovascular targets of vascular endothelial growth factor receptors and platelet-derived growth factor receptor ameliorate thioacetamide induced liver fibrosis in rats
    Xiong, Bin
    Bai, Yaowei
    Liu, Jiacheng
    Li, Tongqiang
    Wang, Yingliang
    Zhou, Chen
    PORTAL HYPERTENSION & CIRRHOSIS, 2024, 3 (01): : 1 - 13
  • [48] The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period
    Osuga, Y.
    Toyoshima, H.
    Mitsuhashi, N.
    Taketani, Y.
    MOLECULAR HUMAN REPRODUCTION, 1995, 1 (02) : 69 - 73
  • [49] Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer
    Koukourakis, MI
    Giatromanolaki, A
    OByrne, KJ
    Comley, M
    Whitehouse, RM
    Talbot, DC
    Gatter, KC
    Harris, AL
    BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 477 - 481
  • [50] Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: relationship to various biological factors
    Volm, M
    Mattern, J
    Koomagi, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (05) : 975 - 979